Literature DB >> 19596056

Striatal neuroprotection with methylene blue.

J C Rojas1, N Simola, B A Kermath, J R Kane, T Schallert, F Gonzalez-Lima.   

Abstract

Recent literature indicates that low-dose Methylene Blue (MB), an autoxidizable dye with powerful antioxidant and metabolic enhancing properties, might prevent neurotoxin-induced neural damage and associated functional deficits. This study evaluated whether local MB may counteract the anatomical and functional effects of the intrastriatal infusion of the neurotoxin rotenone (Rot) in the rat. To this end, stereological analyses of striatal lesion volumes were performed and changes in oxidative energy metabolism in the striatum and related motor regions were mapped using cytochrome oxidase histochemistry. The influence of MB on striatal levels of oxidative stress induced by Rot was determined, and behavioral tests were used to investigate the effect of unilateral MB coadministration on motor asymmetry. Rot induced large anatomical lesions resembling "metabolic strokes," whose size was greatly reduced in MB-treated rats. Moreover, MB prevented the decrease in cytochrome oxidase activity and the perilesional increase in oxidative stress associated with Rot infusion in the striatum. MB also prevented the indirect effects of the Rot-induced lesion on cytochrome oxidase activity in related motor regions, such as the striatal regions rostral and caudal to the lesion, the substantia nigra compacta and reticulata, and the pedunculopontine nucleus. At a network level, MB maintained a global strengthening of functional connectivity in basal ganglia-thalamocortical motor circuits, as opposed to the functional decoupling observed in Rot-alone subjects. Finally, MB partially prevented the behavioral sensorimotor asymmetries elicited by Rot. These results are consistent with protective effects of MB against neurotoxic damage in the brain parenchyma. This study provides the first demonstration of the anatomical, metabolic and behavioral neuroprotective effects of MB in the striatum in vivo, and supports the notion that MB could be a valuable intervention against neural damage associated with oxidative stress and energy hypometabolism.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19596056      PMCID: PMC2765788          DOI: 10.1016/j.neuroscience.2009.07.012

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  70 in total

1.  The effect of rotenone on respiration and its point of attack.

Authors:  P E LINDAHL; K E OBERG
Journal:  Exp Cell Res       Date:  1961-03       Impact factor: 3.905

2.  Behavioral differences in a rotenone-induced hemiparkinsonian rat model developed following intranigral or median forebrain bundle infusion.

Authors:  Kizhakke M Sindhu; Karuppagounder S Saravanan; Kochupurackal P Mohanakumar
Journal:  Brain Res       Date:  2005-07-27       Impact factor: 3.252

3.  Studies on the respiratory chain-linked reduced nicotinamide adenine dinucleotide dehydrogenase. XIV. Location of the sites of inhibition of rotenone, barbiturates, and piericidin by means of electron paramagnetic resonance spectroscopy.

Authors:  G Palmer; D J Horgan; H Tisdale; T P Singer; H Beinert
Journal:  J Biol Chem       Date:  1968-02-25       Impact factor: 5.157

4.  Acute extrapyramidal syndrome in methylmalonic acidemia: "metabolic stroke" involving the globus pallidus.

Authors:  R Heidenreich; M Natowicz; B E Hainline; P Berman; R I Kelley; R E Hillman; G T Berry
Journal:  J Pediatr       Date:  1988-12       Impact factor: 4.406

5.  Extensive cortical rewiring after brain injury.

Authors:  Numa Dancause; Scott Barbay; Shawn B Frost; Erik J Plautz; Daofen Chen; Elena V Zoubina; Ann M Stowe; Randolph J Nudo
Journal:  J Neurosci       Date:  2005-11-02       Impact factor: 6.167

Review 6.  Symmetrical necrosis of the basal ganglia in methylmalonic acidaemia.

Authors:  A M Roodhooft; E R Baumgartner; J J Martin; W Blom; K J Van Acker
Journal:  Eur J Pediatr       Date:  1990-05       Impact factor: 3.183

7.  Neuroprotective effects of near-infrared light in an in vivo model of mitochondrial optic neuropathy.

Authors:  Julio C Rojas; Jung Lee; Joseph M John; F Gonzalez-Lima
Journal:  J Neurosci       Date:  2008-12-10       Impact factor: 6.167

8.  Cytochrome oxidase activity in the auditory system of the mouse: a qualitative and quantitative histochemical study.

Authors:  F Gonzalez-Lima; A Cada
Journal:  Neuroscience       Date:  1994-11       Impact factor: 3.590

9.  CT and MR of the brain in the diagnosis of organic acidemias. Experiences from 107 patients.

Authors:  J Brismar; P T Ozand
Journal:  Brain Dev       Date:  1994-11       Impact factor: 1.961

10.  Complex I deficiency primes Bax-dependent neuronal apoptosis through mitochondrial oxidative damage.

Authors:  Celine Perier; Kim Tieu; Christelle Guégan; Casper Caspersen; Vernice Jackson-Lewis; Valerio Carelli; Andrea Martinuzzi; Michio Hirano; Serge Przedborski; Miquel Vila
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-19       Impact factor: 11.205

View more
  20 in total

Review 1.  Neurometabolic mechanisms for memory enhancement and neuroprotection of methylene blue.

Authors:  Julio C Rojas; Aleksandra K Bruchey; F Gonzalez-Lima
Journal:  Prog Neurobiol       Date:  2011-11-03       Impact factor: 11.685

Review 2.  The role of environmental exposures in neurodegeneration and neurodegenerative diseases.

Authors:  Jason R Cannon; J Timothy Greenamyre
Journal:  Toxicol Sci       Date:  2011-09-13       Impact factor: 4.849

3.  Methylthioninium chloride (methylene blue) induces autophagy and attenuates tauopathy in vitro and in vivo.

Authors:  Erin E Congdon; Jessica W Wu; Natura Myeku; Yvette H Figueroa; Mathieu Herman; Paul S Marinec; Jason E Gestwicki; Chad A Dickey; W Haung Yu; Karen E Duff
Journal:  Autophagy       Date:  2012-04-01       Impact factor: 16.016

4.  Neuroprotective and Functional Improvement Effects of Methylene Blue in Global Cerebral Ischemia.

Authors:  Qing Lu; Donovan Tucker; Yan Dong; Ningjun Zhao; Quanguang Zhang
Journal:  Mol Neurobiol       Date:  2015-10-03       Impact factor: 5.590

Review 5.  Mitochondrial optic neuropathy: In vivo model of neurodegeneration and neuroprotective strategies.

Authors:  Julio C Rojas; Francisco Gonzalez-Lima
Journal:  Eye Brain       Date:  2010-03-10

6.  Cardiac arrest-induced regional blood-brain barrier breakdown, edema formation and brain pathology: a light and electron microscopic study on a new model for neurodegeneration and neuroprotection in porcine brain.

Authors:  Hari Shanker Sharma; Adriana Miclescu; Lars Wiklund
Journal:  J Neural Transm (Vienna)       Date:  2010-10-21       Impact factor: 3.575

7.  Beneficial network effects of methylene blue in an amnestic model.

Authors:  Penny D Riha; Julio C Rojas; F Gonzalez-Lima
Journal:  Neuroimage       Date:  2010-11-16       Impact factor: 6.556

Review 8.  Therapeutic strategies in Friedreich's ataxia.

Authors:  Timothy E Richardson; Heather N Kelly; Amanda E Yu; James W Simpkins
Journal:  Brain Res       Date:  2013-04-13       Impact factor: 3.252

9.  Therapeutic perspectives of drugs targeting Toll-like receptors based on immune physiopathology theory of Alzheimer's disease.

Authors:  Andrew R Schneider; Youssef Sari
Journal:  CNS Neurol Disord Drug Targets       Date:  2014       Impact factor: 4.388

Review 10.  Alternative mitochondrial electron transfer for the treatment of neurodegenerative diseases and cancers: Methylene blue connects the dots.

Authors:  Shao-Hua Yang; Wenjun Li; Nathalie Sumien; Michael Forster; James W Simpkins; Ran Liu
Journal:  Prog Neurobiol       Date:  2015-11-18       Impact factor: 11.685

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.